Feussner G[Author] - Search Results

Year	Number of Results
1977	1
1979	4
1981	2
1982	2
1983	1
1987	1
1988	1
1989	2
1990	4
1991	3
1992	6
1993	4
1994	6
1995	3
1996	7
1997	2
1998	4
1999	1
2000	2
2002	2
2003	1
2025	0

1

Feussner G. Feussner G. Curr Opin Lipidol. 1994 Feb;5(1):59-68. doi: 10.1097/00041433-199402000-00010. Curr Opin Lipidol. 1994. PMID: 15559032 Review.

2

Type III hyperlipoproteinemia in a child with hemolytic uremic syndrome.

Feussner G, Wingen AM, Ziegler R. Feussner G, et al. Metabolism. 1990 Nov;39(11):1196-9. doi: 10.1016/0026-0495(90)90094-s. Metabolism. 1990. PMID: 2233282 Review.

3

Genetics of type III hyperlipoproteinemia.

Feussner G, Piesch S, Dobmeyer J, Fischer C. Feussner G, et al. Genet Epidemiol. 1997;14(3):283-97. doi: 10.1002/(SICI)1098-2272(1997)14:3<283::AID-GEPI6>3.0.CO;2-6. Genet Epidemiol. 1997. PMID: 9181357

4

Effects of apolipoprotein A-I genetic variations on plasma apolipoprotein, serum lipoprotein and glucose levels.

Larson IA, Ordovas JM, Barnard JR, Hoffmann MM, Feussner G, Lamon-Fava S, Schaefer EJ. Larson IA, et al. Among authors: feussner g. Clin Genet. 2002 Mar;61(3):176-84. doi: 10.1034/j.1399-0004.2002.610302.x. Clin Genet. 2002. PMID: 12000358

5

Apolipoprotein E to B ratio: a marker for type III hyperlipoproteinaemia.

März W, Feussner G, Siekmeier R, Donnerhak B, Schaaf L, Ruzicka V, Gross W. März W, et al. Among authors: feussner g. Eur J Clin Chem Clin Biochem. 1993 Nov;31(11):743-7. doi: 10.1515/cclm.1993.31.11.743. Eur J Clin Chem Clin Biochem. 1993. PMID: 8305617

6

Severe xanthomatosis associated with familial apolipoprotein E deficiency.

Feussner G. Feussner G. J Clin Pathol. 1996 Dec;49(12):985-9. doi: 10.1136/jcp.49.12.985. J Clin Pathol. 1996. PMID: 9038735 Free PMC article.

7

Serum amyloid A protein (SAA): a marker for liver allograft rejection in humans.

Feussner G, Stech C, Dobmeyer J, Schaefer H, Otto G, Ziegler R. Feussner G, et al. Clin Investig. 1994 Dec;72(12):1007-11. doi: 10.1007/BF00577745. Clin Investig. 1994. PMID: 7711405

8

Apolipoprotein E5 (Glu212-->Lys): increased binding to cell surface proteoglycans but decreased uptake and lysosomal degradation in cultured fibroblasts.

Feussner G, Scharnagl H, Scherbaum C, Acar J, Dobmeyer J, Lohrmann J, Wieland H, März W. Feussner G, et al. J Lipid Res. 1996 Aug;37(8):1632-45. J Lipid Res. 1996. PMID: 8864947 Free article.

9

Prevalence and association of atherosclerosis at three different arterial sites in patients with type III hyperlipoproteinemia.

Dobmeyer J, Lohrmann J, Feussner G. Dobmeyer J, et al. Among authors: feussner g. Atherosclerosis. 1996 Jan 5;119(1):89-98. doi: 10.1016/0021-9150(95)05633-5. Atherosclerosis. 1996. PMID: 8929260

10

Molecular basis of type III hyperlipoproteinemia in Germany.

Feussner G, Feussner V, Hoffmann MM, Lohrmann J, Wieland H, März W. Feussner G, et al. Hum Mutat. 1998;11(6):417-23. doi: 10.1002/(SICI)1098-1004(1998)11:6<417::AID-HUMU1>3.0.CO;2-5. Hum Mutat. 1998. PMID: 9603433

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

59 results

Results by year